Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Prof Roberto Orecchia speaks to ecancer at the BGICC 2020 conference in Cairo, Egypt about the management of these cancers in pregnant patients.
He states that the number of women who experience cancer during pregnancy is increasing as the age of gestation is also increasing.
Prof Orecchia explains the various treatment approaches available for these patients and emphasises that there is a lack of research and recommendations in this area.
Feasibility and safety of boost at 74 Gy based on interim FDG-PET during thoracic radio-chemotherapy for NSCLC patients
Adjuvant radiotherapy has no benefit following radical prostatectomy
Short-course radiation as effective as standard treatment for breast cancer patients choosing reconstruction after mastectomy
The current status of multiple myeloma diagnosis and treatment
TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer
TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer
The use of IORT at Universitätsmedizin Mannheim hospital
Choosing Wisely in radiology
Epidemiology, detection, and management of NAFLD: a Latin American perspective